ENTEGRIS INC quarterly report, Q2 FY2026

Entegris, Inc. (ENTG) Q2 2026 10-Q Summary

Business Context and Reporting Period

This summary covers the quarterly period ended June 27, 2026. Entegris, Inc. is a leading supplier of critical advanced materials and process solutions for the semiconductor and high-technology industries. The company operates through two segments: Materials Solutions (MS) and Advanced Purity Solutions (APS). As of July 31, 2026, there were 152.8 million shares of common stock outstanding.

Key Financial Metrics

Metric Q2 2026 (3 Months) Q2 2025 (3 Months) YTD 2026 (6 Months) YTD 2025 (6 Months)
Net Sales $883.2 million $792.4 million $1,695.1 million $1,565.6 million
Gross Profit $420.0 million $351.5 million $800.8 million $708.0 million
Gross Margin 47.6% 44.4% 47.2% 45.2%
Operating Income $164.6 million $106.1 million $306.2 million $228.4 million
Net Income $93.6 million $52.8 million $185.6 million $115.7 million
Diluted EPS $0.61 $0.35 $1.21 $0.76
Operating Cash Flow (YTD) $339.2 million (vs. $253.9 million YTD 2025)
Cash & Equivalents $353.6 million (as of June 27, 2026)
Total Debt (Net) $3,456.0 million (as of June 27, 2026)

Material Changes vs. Prior Period

  • Revenue Growth: Net sales increased 11.5% in Q2 and 8.3% YTD, driven primarily by volume growth in both segments. Taiwan sales grew 29% in Q2 and 23% YTD.
  • Margin Expansion: Gross margin improved by 3.2 percentage points in Q2 and 2.0 percentage points YTD. This was driven by higher production volumes and a significant reduction in depreciation expense due to a change in the estimated useful lives of property, plant, and equipment (PP&E).
  • Accounting Change: In January 2026, the company extended the useful lives of certain PP&E assets. This reduced depreciation expense by $18.7 million in Q2 and $37.7 million YTD, increasing net income by approximately $15.3 million and $23.3 million, respectively.
  • Debt Reduction: The company repaid $250.0 million of Term Loan B borrowings during the first six months of 2026. Total debt decreased from $3,697.6 million at year-end 2025 to $3,456.0 million.
  • Restructuring: Restructuring charges totaled $5.6 million in Q2 and $9.7 million YTD, related to workforce reductions and the wind-down of the Life Sciences Fluid Management business.

Guidance, Outlook, and Risks

  • Segment Performance: The APS segment saw significant profit growth (57% in Q2) driven by liquid/gas filtration and FOUP sales. The MS segment grew 5% in sales and 7% in profit.
  • Trade Environment: Management highlights risks from global trade tensions, specifically tariffs imposed by the U.S. and retaliatory measures by other countries, which may increase costs and disrupt supply chains.
  • Geopolitical Risks: Conflicts in the Middle East and Ukraine/Russia continue to create volatility in energy prices and shipping routes, though the company states these do not constitute a material portion of revenue.
  • Subsequent Events: On July 15, 2026, the board declared a quarterly dividend of $0.10 per share. On July 31, 2026, the company made an additional $25 million voluntary debt payment.
  • Non-GAAP Measures: Adjusted EBITDA for Q2 was $250.7 million (28.4% margin), and Non-GAAP EPS was $0.93.

Investor Verification Checklist

  • Depreciation Impact: Verify the sustainability of margin improvements given the one-time accounting change regarding PP&E useful lives.
  • Tariff Exposure: Assess the specific impact of new U.S. tariffs and potential retaliatory measures on the company's cost structure and pricing power.
  • Debt Covenants: Confirm compliance with the 5.20:1.00 first lien net leverage ratio covenant, particularly as the revolving facility utilization remains low.
  • China Demand: Monitor sales trends in China, which saw a slight decline (-1% YTD) due to decreased demand for MS products, amidst broader geopolitical tensions.
  • Restructuring Completion: Track the progress of the Life Sciences Fluid Management wind-down and associated asset impairment charges.